Search
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Search in posts
Search in pages
Search in groups
Search in users
Search in forums
Filter by Custom Post Type
Filter by Categories
Filter by Report Categories
Advance Interior Materials
Agriculture Industry
Agrochemicals & fertilizers
Animal feed and feed additives
Automotive Sector
Automotive & Transportation
Biotechnology
Building & Construction
Building & Construction Materials
Electronics & Semiconductors
Electronic Devices
Electronic Security
Energy & Resources
Alternative Energy
Distribution & Utilities
Power generation and storage
Food & Beverage
Food Additives and Nutricosmetics
Life Sciences
Healthcare
Wellness
Personal Care & Cosmetics
Materials & Chemicals
Advanced Materials
Advanced Materials (Green Building Materials)
Ceramic & Fiber
Coatings & printing inks
Organic Chemicals
Paints
Petrochemicals
Plastics
Polymers & Resins
Renewable Chemicals
Specialty & Fine Chemicals
Specialty glass
Specialty Polymer
Medical Devices
Pharmaceuticals
Clinic Diagnostics
Technology & Media
Communication Infrastructure
Communication Services
HVAC and Construction
Next Generation Technologies
Textiles
Smart Textiles
{ "homeurl": "https://www.marketresearchandstatistics.com/", "resultstype": "vertical", "resultsposition": "hover", "itemscount": 4, "imagewidth": 70, "imageheight": 70, "resultitemheight": "auto", "showauthor": 0, "showdate": 0, "showdescription": 1, "charcount": 3, "noresultstext": "No results!", "didyoumeantext": "Did you mean:", "defaultImage": "https://www.marketresearchandstatistics.com/wp-content/plugins/ajax-search-pro/img/default.jpg", "highlight": 0, "highlightwholewords": 1, "openToBlank": 0, "scrollToResults": 0, "resultareaclickable": 1, "autocomplete": { "enabled": 1, "googleOnly": 0, "lang": "en" }, "triggerontype": 1, "triggeronclick": 1, "triggeronreturn": 1, "triggerOnFacetChange": 0, "overridewpdefault": 0, "redirectonclick": 1, "redirectClickTo": "results_page", "redirect_on_enter": 1, "redirectEnterTo": "results_page", "redirect_url": "?s={phrase}", "more_redirect_url": "?s={phrase}", "settingsimagepos": "left", "settingsVisible": 0, "hresulthidedesc": "0", "prescontainerheight": "400px", "pshowsubtitle": "0", "pshowdesc": "1", "closeOnDocClick": 1, "iifNoImage": "description", "iiRows": 2, "iiGutter": 5, "iitemsWidth": 200, "iitemsHeight": 200, "iishowOverlay": 1, "iiblurOverlay": 1, "iihideContent": 1, "loaderLocation": "auto", "analytics": 0, "analyticsString": "", "aapl": { "on_click": 0, "on_magnifier": 0, "on_enter": 0, "on_typing": 0 }, "compact": { "enabled": 0, "width": "100%", "closeOnMagnifier": 1, "closeOnDocument": 0, "position": "static", "overlay": 0 }, "animations": { "pc": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "fadeInDown" }, "mob": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "voidanim" } }, "autop": { "state": "disabled", "phrase": "", "count": 10 } }

Oncomatryx Biopharma, S.L. – Product Pipeline Review – 2015

$1,500

Global Markets Direct’s, ‘Oncomatryx Biopharma, S.L. – Product Pipeline Review – 2015’, provides an overview of the Oncomatryx Biopharma, S.L.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Oncomatryx Biopharma, S.L.’s, complete with comparative analysis…

Total Pages: 24

oncomatryx-biopharma-s-l-product-pipeline-review-2015
600
#9e2f22

Global Markets Direct’s, ‘Oncomatryx Biopharma, S.L. - Product Pipeline Review - 2015’, provides an overview of the Oncomatryx Biopharma, S.L.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Oncomatryx Biopharma, S.L.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Oncomatryx Biopharma, S.L. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Oncomatryx Biopharma, S.L.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Oncomatryx Biopharma, S.L.’s pipeline products

Reasons to buy

- Evaluate Oncomatryx Biopharma, S.L.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Oncomatryx Biopharma, S.L. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Oncomatryx Biopharma, S.L.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Oncomatryx Biopharma, S.L. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Oncomatryx Biopharma, S.L.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Oncomatryx Biopharma, S.L. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Oncomatryx Biopharma, S.L. Snapshot 5
Oncomatryx Biopharma, S.L. Overview 5
Key Information 5
Key Facts 5
Oncomatryx Biopharma, S.L. - Research and Development Overview 6
Key Therapeutic Areas 6
Oncomatryx Biopharma, S.L. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Oncomatryx Biopharma, S.L. - Pipeline Products Glance 10
Oncomatryx Biopharma, S.L. - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Discovery Products/Combination Treatment Modalities 11
Oncomatryx Biopharma, S.L. - Drug Profiles 12
OMTX-001 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
OMTX-503 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
OMTX-505 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
OMTX-705 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
OMTX-007 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
OMTX-703 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Oncomatryx Biopharma, S.L. - Pipeline Analysis 18
Oncomatryx Biopharma, S.L. - Pipeline Products by Target 18
Oncomatryx Biopharma, S.L. - Pipeline Products by Molecule Type 19
Oncomatryx Biopharma, S.L. - Pipeline Products by Mechanism of Action 20
Oncomatryx Biopharma, S.L. - Dormant Projects 21
Oncomatryx Biopharma, S.L. - Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 23
Disclaimer 24

List of Tables
Oncomatryx Biopharma, S.L., Key Information 5
Oncomatryx Biopharma, S.L., Key Facts 5
Oncomatryx Biopharma, S.L. - Pipeline by Indication, 2015 7
Oncomatryx Biopharma, S.L. - Pipeline by Stage of Development, 2015 8
Oncomatryx Biopharma, S.L. - Monotherapy Products in Pipeline, 2015 9
Oncomatryx Biopharma, S.L. - Preclinical, 2015 10
Oncomatryx Biopharma, S.L. - Discovery, 2015 11
Oncomatryx Biopharma, S.L. - Pipeline by Target, 2015 18
Oncomatryx Biopharma, S.L. - Pipeline by Molecule Type, 2015 19
Oncomatryx Biopharma, S.L. - Pipeline Products by Mechanism of Action, 2015 20
Oncomatryx Biopharma, S.L. - Dormant Developmental Projects,2015 21

List of Figures
Oncomatryx Biopharma, S.L. - Pipeline by Top 10 Indication, 2015 7
Oncomatryx Biopharma, S.L. - Pipeline by Stage of Development, 2015 8
Oncomatryx Biopharma, S.L. - Monotherapy Products in Pipeline, 2015 9
Oncomatryx Biopharma, S.L. - Pipeline by Top 10 Target, 2015 18
Oncomatryx Biopharma, S.L. - Pipeline by Top 10 Molecule Type, 2015 19
Oncomatryx Biopharma, S.L. - Pipeline Products by Top 10 Mechanism of Action, 2015 20


LICENSE TYPE